Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Analytical Chemistry|January 19, 2022
Rapid Targeted Quantitation of Protein Overexpression with Direct Infusion Shotgun Proteome Analysis (DISPA-PRM)Edna A Trujillo, Alexander S Hebert, Julio C Rivera Vazquez, et al.
Antiviral Therapy|February 2, 2012
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatmentIngmar Mederacke, Cihan Yurdaydin, George N Dalekos, et al.
Plant Direct|June 28, 2019
High-throughput droplet microfluidics screening platform for selecting fast-growing and high lipid-producing microalgae from a mutant libraryHyun Soo Kim, Shih-Chi Hsu, Song-I Han, et al.
Msystems|March 30, 2023
Systematic Analysis of Metabolic Bottlenecks in the Methylerythritol 4-Phosphate (MEP) Pathway of Zymomonas mobilisDaven B Khana, Mehmet Tatli, Julio Rivera Vazquez, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis deltaBenjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, et al.
Journal of Viral Hepatitis|March 15, 2025
Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D InfectionSvenja Hardtke, Cihan Yurdaydin, Florin A Caruntu, et al.
United European Gastroenterology Journal|November 29, 2025
Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination TherapyCihan Yurdaydin, Julia Kahlhöfer, Florin Alexandru Caruntu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2020
Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II studyBirgit Bremer, Olympia E Anastasiou, Svenja Hardtke, et al.
Hepato-Gastroenterology|March 13, 2013
Single-center analysis of the first 304 living-donor liver transplantations in 3 yearsSezai Yilmaz, Cuneyt Kayaalp, Cengiz Ara, et al.
Journal of Viral Hepatitis|November 13, 2020
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reductionOlympia E Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, et al.
Pageof 11